| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
2
5
2
|
|
Zacks Investment Research
4
(Sell)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
E+
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 3.15 | 3.15 |
| Stocks | 0.0 | 0.0 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 96.85 | 96.85 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Sanofi | SAN | --- | 2.77 |
| Samsung Electronics Co Ltd | SSNLF | 0.0 | 2.58 |
| Telenor ASA | TEL | --- | 2.27 |
| Roche Holding AG | RHHVF | 23.65 | 2.24 |
| GlaxoSmithKline PLC | GLAXF | 20.09 | 2.21 |
| Bayer AG | BAYN | --- | 1.95 |
| DBS Group Holdings Ltd | D05 | --- | 1.84 |
| Vodafone Group PLC | VODPF | 21.77 | 1.83 |
| Merck KGaA | MRK | --- | 1.78 |
| Swiss Re AG | SREN | --- | 1.76 |
